NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody
Ying Gong(Nanfang Hospital), Roel G. J. Klein Wolterink(Maastricht University Medical Centre)
Cited by 28
Related Papers
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy
|Journal of Hematology & Oncology|2021|364